Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Griffard-Smith

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|March 27, 2026
Integrative modeling of read depth and B-allele frequency improves single-cell copy number calling from targeted DNA sequencing panelsDong Pei, Rachel Griffard-Smith, Brahian Cano Urrego, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2025
Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel diseaseDebolina Dasgupta, Aprajita Tripathi, Rachel Griffard-Smith, et al.
Frontiers in Bioinformatics|May 23, 2025
micRoclean: an R package for decontaminating low-biomass 16S-rRNA microbiome dataRachel Griffard-Smith, Emily Schueddig, Diane E Mahoney, et al.
Gut Microbes Reports|February 23, 2026
Distinguishing the significance of blood microbes in epithelial ovarian cancerDiane E Mahoney, Prabhakar Chalise, Dong Pei, et al.
Cell Reports|August 26, 2025
Nrf2 drives activation-driven expansion of CD4<sup>+</sup>T cells by modulating glucose and glutamine metabolismAprajita Tripathi, Debolina Dasgupta, Michael S Dahabieh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|March 27, 2026
Integrative modeling of read depth and B-allele frequency improves single-cell copy number calling from targeted DNA sequencing panelsDong Pei, Rachel Griffard-Smith, Brahian Cano Urrego, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2025
Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel diseaseDebolina Dasgupta, Aprajita Tripathi, Rachel Griffard-Smith, et al.
Frontiers in Bioinformatics|May 23, 2025
micRoclean: an R package for decontaminating low-biomass 16S-rRNA microbiome dataRachel Griffard-Smith, Emily Schueddig, Diane E Mahoney, et al.
Gut Microbes Reports|February 23, 2026
Distinguishing the significance of blood microbes in epithelial ovarian cancerDiane E Mahoney, Prabhakar Chalise, Dong Pei, et al.
Cell Reports|August 26, 2025
Nrf2 drives activation-driven expansion of CD4<sup>+</sup>T cells by modulating glucose and glutamine metabolismAprajita Tripathi, Debolina Dasgupta, Michael S Dahabieh, et al.
Pageof 1